GlassScriptPhysician profile
Betsy Kendis
NPI 1326049081
$2,437.63
in general payments reported to CMS, 2019-2025
26 companies · $705 in 2025
The $705 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $48.31 · 2022: $489 · 2023: $408 · 2024: $427 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,540.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $492.97 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Novo Nordisk INC | $344.95 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $269.76 | 2023-2025 | Breztri, Farxiga |
| Glaxosmithkline, LLC. | $171.12 | 2019-2025 | Bexsero, Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $158.76 | 2020-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Sanofi Pasteur INC. | $154.97 | 2019-2023 | |
| Pfizer INC. | $134.04 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $123.86 | 2024-2025 | Gemtesa |
| Corium, LLC | $73.48 | 2022 | |
| Exact Sciences Corporation | $70.51 | 2023-2025 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $70.36 | 2022-2023 | Injectafer |
| Biohaven Pharmaceutical Holding Company LTD. | $69.62 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $47.83 | 2023 | |
| Allergan, INC. | $36.10 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $26.41 | 2025 | Voquezna |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.68 | 2019 | |
| Inspire Medical Systems, INC. | $25.33 | 2025 | Inspire |
| Mayne Pharma Commercial LLC | $22.38 | 2022 | |
| Genentech USA, INC. | $19.31 | 2019 | |
| Cranial Technologies, INC | $15.80 | 2019 | |
| Xeris Pharmaceuticals, INC. | $15.40 | 2024 | Recorlev |
| Edwards Lifesciences Corporation | $15.00 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Amneal Pharmaceuticals LLC | $14.64 | 2022 | |
| Abbvie INC. | $14.63 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.78 | 2022 | |
| Tactile Systems Technology INC | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Betsy Kendis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.